BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited has announced a new proposal to issue 62 million ordinary fully paid securities, with the target date for issuing set for June 11, 2024. This move, pending approval from the ASX for quotation on a deferred settlement basis, could potentially stimulate investor interest and impact the company’s market dynamics.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
